RJA
BLUE

Raymond James & Associates’s bluebird bio BLUE Stock Holding History

Raymond James & Associates’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-706
Closed -$46.4K – 3809
2023
Q2 		$46.4K Sell
706
-7
-1% -$512 ﹤0.01% 3715
2023
Q1 		$45.3K Buy
713
+50
+8% +$5.71K ﹤0.01% 3739
2022
Q4 		$91.8K Sell
663
-17
-3% -$2.4K ﹤0.01% 3659
2022
Q3 		$86K Buy
+680
New +$76.9K ﹤0.01% 3638
2022
Q2 		– Sell
-513
Closed -$50K – 4039
2022
Q1 		$50K Buy
+513
New +$67.7K ﹤0.01% 3910
2021
Q1 		– Sell
-1,460
Closed -$818K – 4006
2020
Q4 		$818K Sell
1,460
-490
-25% -$311K ﹤0.01% 2469
2020
Q3 		$1.36M Buy
1,950
+431
+28% +$336K ﹤0.01% 1993
2020
Q2 		$1.2M Buy
1,519
+986
+185% +$744K ﹤0.01% 2032
2020
Q1 		$317K Buy
533
+20
+4% +$19.5K ﹤0.01% 2726
2019
Q4 		$583K Buy
513
+144
+39% +$157K ﹤0.01% 2617
2019
Q3 		$439K Buy
369
+28
+8% +$42.8K ﹤0.01% 2741
2019
Q2 		$562K Buy
341
+16
+5% +$27.7K ﹤0.01% 2577
2019
Q1 		$662K Buy
325
+79
+32% +$139K ﹤0.01% 2471
2018
Q4 		$316K Buy
246
+59
+32% +$90.5K ﹤0.01% 2830
2018
Q3 		$353K Sell
187
-96
-34% -$198K ﹤0.01% 2936
2018
Q2 		$575K Sell
283
-26
-8% -$59.3K ﹤0.01% 2584
2018
Q1 		$683K Sell
309
-62
-17% -$158K ﹤0.01% 2374
2017
Q4 		$855K Buy
371
+81
+28% +$164K ﹤0.01% 2214
2017
Q3 		$516K Buy
290
+138
+91% +$193K ﹤0.01% 2470
2017
Q2 		$207K Sell
152
-36
-19% -$43.4K ﹤0.01% 2963
2017
Q1 		$221K Buy
+188
New +$192K ﹤0.01% 2875

Other funds holding BLUE

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Raymond James & Associates's BLUE Position: Q3 2023 in Review

Raymond James & Associates sold out of bluebird bio (BLUE) in Q3 2023, closing a stake of 706 shares — an estimated $46.4K sold.

Raymond James & Associates first reported a position in BLUE in Q1 2017 and held it in 21 quarters. The position peaked at $1.36M in Q3 2020. 168 funds tracked by Wall St. Rank hold BLUE as of Q3 2023.

  • Raymond James & Associates reported no remaining bluebird bio position as of Q3 2023 after selling out during the quarter.
  • Raymond James & Associates sold 706 bluebird bio shares in Q3 2023, an estimated $46.4K.
  • Raymond James & Associates first reported a position in bluebird bio in Q1 2017 and held it in 21 quarters.
  • Raymond James & Associates's bluebird bio position peaked at $1.36M in Q3 2020.
  • 168 funds tracked by Wall St. Rank held bluebird bio as of Q3 2023.

Based on Raymond James & Associates's 13F filing for Q3 2023, filed 24 Oct 2023.